Evidence map›Paper›PMID 39051297›Full record

ArticleClinics and practice2024

Time-to-Treatment Delays and Their Prognostic Implications in Pharyngeal Cancer-An Exploratory Analysis in Western Romania.

Andreea Mihaela Kiș, Roxana Buzatu, Lazar Chisavu, Marioara Poenaru, Claudia Borza, Andrada Iftode, Oana Silvana Sarau, Cristina Adriana Dehelean, Simona Ardelean

Abstract read
In one paragraph

Article in Clinics and practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andreea Mihaela KișFaculty of Pharmacy, "Victor Babeș" University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timișoara, Romania.ORCID 0009-0004-4581-8487
Roxana BuzatuDepartment of Dental Aesthetics, Faculty of Dental Medicine, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania.ORCID 0000-0003-0653-0996
Lazar ChisavuDepartment of Nephrology, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania.ORCID 0000-0003-3664-1945
Marioara PoenaruDepartment of ENT, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania.
Claudia BorzaDepartment of Functional Sciences-Pathophysiology, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania.
Andrada IftodeFaculty of Pharmacy, "Victor Babeș" University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timișoara, Romania.
Oana Silvana SarauDepartment of Hematology, "Victor Babeș" University of Medicine and Pharmacy, 300041 Timișoara, Romania.
Cristina Adriana DeheleanFaculty of Pharmacy, "Victor Babeș" University of Medicine and Pharmacy, Eftimie Murgu Square No. 2, 300041 Timișoara, Romania.
Simona ArdeleanDepartment of Pharmaceutical Technology, Faculty of Pharmacy, "Vasile Goldiș" Western University, 86 Liviu Rebreanu, 310045 Arad, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiagnosis and treatment for pharyngeal cancer are decisive in determining prognosis. Diagnosis delays are frequent, representing a significant cause of avoidable mortality, and an important factor in subpar survival across the continuous HNC care delivery.

methodsThe present study represents a retrospective analysis of medical records from Western Romania, which included 180 patients, to evaluate the impact of time-to-treatment delay on patients diagnosed with pharyngeal cancer. The data analyses were performed using the Kaplan-Meier method R (version 3.6.3) packages, including tidyverse, final-fit, mcgv, survival, stringdist, janitor, and Hmisc.

resultsThe mean days from diagnosis until the end of treatment were higher for the nasopharynx group. Cox regression analysis regarding diagnosis to treatment duration categories showed an increased risk mortality by 3.11 times (95%CI: 1.51-6.41,

conclusionsThe findings of this study led to the conclusion that it seems there is a trend of mortality risk for oropharynx and hypopharynx cancers due to delays in the time to treatment over 70 days, standing as a basis for further research as there is an imperative need for prospective multicenter studies.

Indexed as

delayed diagnosisoverall survivalpharyngeal cancertime to treatment

Identifiers

PMID39051297
PMCPMC11270176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.